Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Meeting Results* for: March 4, 2009

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Sancuso	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Moxatag	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Astepro	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Trilipix	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Stavzor	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Janumet	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required
Banzel	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Tekturna HCT	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Letairis	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Requirement Removed
Megace ES	New Drug Appeal	Require Prior Approval	Prior Approval Required
Bystolic	New Drug Appeal	Remove Prior Approval Requirement	Prior Approval Required
Pristiq	New Drug Appeal	Require Prior Approval	Prior Approval Required
Keppra XR	New Drug Appeal	Require Prior Approval	Prior Approval Required
Exforge	New Drug Appeal	Require Prior Approval	Prior Approval Required
Tekturna	New Drug Appeal	Require Prior Approval	Prior Approval Required